Evidence map›Paper›PMID 31871090›Full record

ArticleAntimicrobial agents and chemotherapy2020

Aspergillus fumigatus Clinical Isolates Carrying CYP51A with TR34/L98H/S297T/F495I Substitutions Detected after Four-Year Retrospective Azole Resistance Screening in Brazil.

Laís Pontes, Caio Augusto Gualtieri Beraquet, Teppei Arai, Guilherme Leite Pigolli, Luzia Lyra, Akira Watanabe, Maria Luiza Moretti, Angélica Zaninelli Schreiber

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 34 citations in OpenAlex.

  1. One health (Amsterdam, Netherlands) · 2026
    Article
  2. Global epidemiology of azole resistance inJAC-antimicrobial resistance · 2026
    Review
  3. A One Health Perspective onJournal of fungi (Basel, Switzerland) · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Enhancing Antifungal Drug Discovery Through Co-Culture with AntarcticInternational journal of molecular sciences · 2024
    Article
  9. Insights intoJournal of fungi (Basel, Switzerland) · 2024
    Article
  10. Article
  11. Uncovering a NovelJournal of fungi (Basel, Switzerland) · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Selection ofMedical mycology case reports · 2022
    Article
  17. Phylogenetic Distribution ofMicrobiology spectrum · 2021
    Article
  18. Review
  19. Article
  20. Studies in mycology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Laís PontesSchool of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil.
Caio Augusto Gualtieri BeraquetSchool of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil.
Teppei AraiMedical Mycology Research Center, Chiba University, Chiba, Japan.
Guilherme Leite PigolliSchool of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil.
Luzia LyraSchool of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil.
Akira WatanabeMedical Mycology Research Center, Chiba University, Chiba, Japan.
Maria Luiza MorettiSchool of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil.
Angélica Zaninelli SchreiberSchool of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil zaninele@unicamp.br.ORCID 0000-0002-5095-5054
Universidade Estadual de Campinas (UNICAMP) · BRChiba University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Azole antifungal resistance in

Indexed as

Antifungal AgentsAspergillus fumigatusAzolesBrazilCytochrome P-450 Enzyme SystemDrug Resistance, FungalFungal ProteinsHumansMicrobial Sensitivity TestsMicrosatellite RepeatsMutation, MissenseRetrospective StudiesTandem Repeat SequencesAntifungal AgentsAzolescytochrome P-450 CYP51A, AspergillusCytochrome P-450 Enzyme SystemFungal ProteinsAspergillus fumigatusazole resistancedrug resistance mechanisms

Identifiers

PMID31871090
PMCPMC7038256
OpenAlexW2997733082

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.